Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 9/2008

01-09-2008 | Research Articles

Adjuvant chemotherapy for early-stage non-small-cell lung cancer. Single-centre experience and literature review

Authors: Ana Belén Custodio Carretero, José Ángel García Sáenz, José Luis González Larriba, Jana Bobokova, Antonio Calles Blanco, Florentino Hernando Trancho, Beatriz García Paredes, Laura Rodríguez Lajusticia, Eduardo Díaz-Rubio García

Published in: Clinical and Translational Oncology | Issue 9/2008

Login to get access
Metadata
Title
Adjuvant chemotherapy for early-stage non-small-cell lung cancer. Single-centre experience and literature review
Authors
Ana Belén Custodio Carretero
José Ángel García Sáenz
José Luis González Larriba
Jana Bobokova
Antonio Calles Blanco
Florentino Hernando Trancho
Beatriz García Paredes
Laura Rodríguez Lajusticia
Eduardo Díaz-Rubio García
Publication date
01-09-2008
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 9/2008
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-008-0251-x

Other articles of this Issue 9/2008

Clinical and Translational Oncology 9/2008 Go to the issue

News and Views

Onco-pneuma

Research Articles

Prognostic value of the detection of lymph node micrometastases in colon cancer

Brief Research Articles

Protein energy malnutrition (PEM) in cancer patients

Correspondence

An autopsy case of acute pulmonary toxicity related to irinotecan

Educational Series

Molecular biology of pancreatic cancer

Case Reports

Drug-related hepatotoxicity and hepatic failure following combined androgen blockade
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits